Name: 13,14-dihydro-15-keto Prostaglandin E2
Rating: 5 (10 reviews)

有库存

sdf 文件

结构编辑

类似物检索

HIT ID:HIT218832635
Cas No:
常用名:13,14-dihydro-15-keto Prostaglandin E2
常用名:13,14-dihydro-15-keto Prostaglandin E2
别名:13,14-dihydro-15-keto PGE2
IUPAC:7-[3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
IUPAC:7-[3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
InChI key:CUJMXIQZWPZMNQ-UHFFFAOYSA-N

分子式:C20H32O5
分子量:352.471
氢键供体数 (HBD):
氢键受体数 (HBA):
LogP:
SMILES:CCCCCC(=O)CCC1C(O)CC(=O)C1CC=CCCCC(O)=O
SMILES:CCCCCC(=O)CCC1C(O)CC(=O)C1CC=CCCCC(O)=O

13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) serves as the predominant metabolite of PGE2 in plasma, created through a 15-keto PGE2 intermediate by the action of 15-oxo-PG Δ13 reductase. Unlike its precursor PGE2, this compound exhibits poor binding affinity towards EP2 and EP4 PGE2 receptors (Ki values of 12 and 57 µM, respectively) in CHO cells and fails to stimulate adenylate cyclase activity therein (EC50s >18 and >38 µM, respectively). Concentrations of 13,14-dihydro-15-keto PGE2 are notably higher in the plasma of pregnant women during their third trimester and at labor and delivery stages, whereas its levels are found to be reduced in the tumor tissues of patients with non-small cell lung cancer (NSCLC) compared to adjacent healthy tissue.

市场产品/服务共显示1个结果

您无法确定哪种化合物库最适合您的项目？或者您需要定制解决方案？Anymole随时为您提供帮助。

电话：400820-0310

合作：info@screeningcompound.com

技术支持：tech@screeningcompound.com

客服：service@screeningcompound.com

正在加载 ~